Larvol Delta - MORNINGSKY-Study-to-Evaluate-the-Effects-of-RO7496998-AT527-in-NonHospitalized-Adult-and-Adolescent-Participants-With-Mild-or-Moderate-COVID19

bemnifosbuvir (AT-527) - Atea Pharma

http://clinicaltrials.gov/ct2/show/NCT04889040

Jan 4, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next